Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Staib

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Drug Targets. Infectious Disorders|October 8, 2003
Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen deliveryGerd Sutter, Caroline Staib
Current Opinion in Biotechnology|November 25, 2004
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?Ingo Drexler, Caroline Staib, Gerd Sutter
Methods in Molecular Biology (Clifton, N.J.)|April 29, 2004
Construction and isolation of recombinant MVACaroline Staib, Ingo Drexler, Gerd Sutter
The Journal of General Virology|June 17, 2005
Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus AnkaraCaroline Staib, Sigrid Kisling, Volker Erfle, et al.
The Journal of General Virology|September 12, 2006
Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus AnkaraCaroline Staib, Yasemin Suezer, Sigrid Kisling, et al.
Virology|September 9, 2008
In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequencesSusanne El-Gogo, Britta Flach, Caroline Staib, et al.
The Journal of Gene Medicine|September 26, 2008
Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitizationMelanie Albrecht, Yasemin Suezer, Caroline Staib, et al.
Journal of Virology|April 10, 2009
The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cellsKarin M Sperling, Astrid Schwantes, Caroline Staib, et al.
The Journal of Gene Medicine|December 14, 2007
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge modelSusanne El-Gogo, Caroline Staib, Juan José Lasarte, et al.
Journal of Virology|February 1, 2005
Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genesHolger Ludwig, Jörg Mages, Caroline Staib, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Drug Targets. Infectious Disorders|October 8, 2003
Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen deliveryGerd Sutter, Caroline Staib
Current Opinion in Biotechnology|November 25, 2004
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?Ingo Drexler, Caroline Staib, Gerd Sutter
Methods in Molecular Biology (Clifton, N.J.)|April 29, 2004
Construction and isolation of recombinant MVACaroline Staib, Ingo Drexler, Gerd Sutter
The Journal of General Virology|June 17, 2005
Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus AnkaraCaroline Staib, Sigrid Kisling, Volker Erfle, et al.
The Journal of General Virology|September 12, 2006
Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus AnkaraCaroline Staib, Yasemin Suezer, Sigrid Kisling, et al.
Virology|September 9, 2008
In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequencesSusanne El-Gogo, Britta Flach, Caroline Staib, et al.
The Journal of Gene Medicine|September 26, 2008
Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitizationMelanie Albrecht, Yasemin Suezer, Caroline Staib, et al.
Journal of Virology|April 10, 2009
The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cellsKarin M Sperling, Astrid Schwantes, Caroline Staib, et al.
The Journal of Gene Medicine|December 14, 2007
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge modelSusanne El-Gogo, Caroline Staib, Juan José Lasarte, et al.
Journal of Virology|February 1, 2005
Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genesHolger Ludwig, Jörg Mages, Caroline Staib, et al.
Pageof 3